HemaSphere Journal
HemaSphere Journal
  • 23
  • 1 161
NOTCH1 fusions in T‐LBL
Authors of this recent HemaSphere published paper discovered a high-risk subgroup of pediatric T-LBL, defined by NOTCH1 gene fusions. This finding will have an important impact on newly diagnosed children with T-LBL globally, listen to two of the co-authors, Dr Jan Loeffen and Professor Roland Kuipers discuss their findings with Dr Charles de Bock, how they discovered them, and dreams of future developments in this HemaSphere podcast episode.
NOTCH1 fusions in T‐LBL, is on our website and all major podcast platforms (Spotify, Apple Podcast, and more)
Listen and enjoy casual, insightful discussions about #hematology research.
You can find the referenced article, in full and open access, here on the HemaSphere website.
onlinelibrary.wiley.com/doi/full/10.1002/hem3.117
Переглядів: 4

Відео

A transcriptional cofactor‐mediated dependency module
Переглядів 728 днів тому
In this newest podcast episode, Dr Charles de Bock hosts Dr Thomas Mercher and Dr Alexandre Fagnan. This episode is based on their recent paper, “The ETO2 transcriptional co-factor maintains acute leukemia by driving a MYB/EP300-dependent stemness program”, highlighting ETO2 activated gene transcription and how this affects erythroleukemia. The discussion traces the journey from part of Dr Fagn...
Unraveling the secrets of thrombopoiesis
Переглядів 363 місяці тому
Welcome to Season 2 of our podcast! In this episode, Dr. Francesca Vinchi interviews Professor Alessandra Balduini about thrombopoiesis. They explore Prof. Balduini's journey into research, her intuition that led to silk scaffolding, and her hopes on future results. "Unraveling the secrets of thrombopoiesis", is on our website and all major podcast platforms (Spotify, Apple Podcast, UA-cam, etc...
Meet the editors question: What is the most important key skill needed as a peer reviewer?
Переглядів 913 місяці тому
What skills are most important when serving as a manuscript peer reviewer? Our editors weigh in. This is the final topic of the second season of HemaSphere’s ‘Meet the Editors’ series, offering short, casual anecdotes from our experts. We hope you have enjoyed meeting our team. You can replay the full Meet the Editors seasons 1 and 2 on our UA-cam channel at any time.
Meet the editors question: What piece of advice as an aspiring scientist/researcher has stayed?
Переглядів 293 місяці тому
Have you ever received a piece of advice that has remained applicable no matter how life has twisted and turned? Our editors share their most lasting advice received from when they were aspiring scientists and researchers. This is topic 4 of the second season of HemaSphere’s ‘Meet the Editors’ series, offering short, casual anecdotes from our experts. Get to know our team and hear their insight...
Meet the editors question: What is the most rewarding aspect of being involved in HemaSphere?
Переглядів 133 місяці тому
Schedules are busy and priorities diverse - how do you decide where to focus your time? Hear from some of our editors as to what’s so rewarding about being involved with HemaSphere. This is topic 3 of the 2nd season of HemaSphere’s ‘Meet the Editors’ series, offering short, casual anecdotes from our experts. Get to know our team and hear their insights about hematology & publishing topics. www....
HemaSphere Looks Forward to EHA2024
Переглядів 114 місяці тому
✈️...and we're off: the HemaSphere EHA team is heading to Madrid for #EHA2024 and really looking forward to meeting many of you. Most of our brilliant editors will be en route soon. See what HemaSphere's Chief and Deputy Chief Editor are looking forward to! www.hemaspherejournal.com
Meet the editors: If you could choose to witness any scientific breakthrough, what would it be?
Переглядів 594 місяці тому
This is topic 2 of the 2nd season of HemaSphere’s ‘Meet the Editors’ series, offering short, casual anecdotes from our experts. Get to know our team and hear their insights about hematology & publishing topics. www.hemaspherejournal.com
Meet the editors question: What is the most exciting research topic you have come across recently?
Переглядів 304 місяці тому
What is the most exciting research topic a few of our journal editors have come across recently? This is topic 1 of the second season of HemaSphere’s ‘Meet the Editors’ series, which offers short, casual anecdotes from our editors. Get to know our team and hear their insights about hematology & publishing topics. #ScientificPublishing #HemaSphereHumans HemaSphere is #OpenAccess📷: hemaspherejour...
What’s so Great About the P-value? A Statistician’s Point of View
Переглядів 4510 місяців тому
What’s so Great About the P-value? A Statistician’s Point of View Dr Stephen Hibbs invites HemaSphere Associate Editor Prof Robert K Hills to discuss statistics in scientific writing in an entertaining and informative episode: What’s so Great About the P-value? A Statistician’s Point of View. The discussion covers the overlap of statistics and hematology with themes like the importance of P val...
This Is Going to Hurt: Revisiting the Patient Experience of Bone Marrow Biopsies
Переглядів 4911 місяців тому
Dr Stephen Hibbs invites Dr Joseph Taylor to a discussion based on Dr Hibbs popular HemaTopics article, This Is Going to Hurt: Revisiting the Patient Experience of Bone Marrow Biopsies. The conversation ranges from training providers receive to perform bone marrow biopsies, how to talk to patients about these bone marrow biopsies, and some of the outstanding questions about bone marrow biopsies...
The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children
Переглядів 66Рік тому
Though many advances have been made in neutropenias, diagnosis and management are still based on physicians’ experience or local practices. Dr Francesca Fioredda and Prof Helen Papadaki, two co-authors of the HemaSphere published article The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNe...
Part 1 - Comprehensive Diagnosis and Management of POEMS Syndrome
Переглядів 352Рік тому
POEMS syndrome (Polyneuropathy Organomegaly, Endocrinopathy, M-protein and Skin changes) is rare, and systemic manifestations are commonly overlooked initially. Diagnosis is often delayed 12-16 months, during which patients can be severely disabled. No established treatment guidelines exist for POEMS. A recent HemaSphere published article Comprehensive Diagnosis and Management of POEMS Syndrome...
Comprehensive Diagnosis and Management of POEMS Syndrome, Part 2
Переглядів 205Рік тому
POEMS syndrome (Polyneuropathy Organomegaly, Endocrinopathy, M-protein and Skin changes) is rare, and systemic manifestations are commonly overlooked initially. Diagnosis is often delayed 12-16 months, during which patients can be severely disabled. No established treatment guidelines exist for POEMS. A recent HemaSphere published article Comprehensive Diagnosis and Management of POEMS Syndrome...
Meet the Editors Question: In your line of work, what do you do to de-stress or refocus?
Переглядів 6Рік тому
Meet the Editors Question: In your line of work, what do you do to de-stress or refocus?
Meet the Editors Question: Favorite place to review a manuscript?
Переглядів 4Рік тому
Meet the Editors Question: Favorite place to review a manuscript?
Meet the Editors Question: What, in your opinion, makes HemaSphere stand out?
Переглядів 15Рік тому
Meet the Editors Question: What, in your opinion, makes HemaSphere stand out?
Meet the Editors Question: What inspired you to specialize in hematology?
Переглядів 14Рік тому
Meet the Editors Question: What inspired you to specialize in hematology?
Machine Learning Improves Risk Stratification in Myelofibrosis
Переглядів 41Рік тому
Machine Learning Improves Risk Stratification in Myelofibrosis
Meet the Editors Question: What is your top tip for getting your work published?
Переглядів 30Рік тому
Meet the Editors Question: What is your top tip for getting your work published?
EHA ANNA FALANGA FINAL 1Jun2023
Переглядів 16Рік тому
EHA ANNA FALANGA FINAL 1Jun2023
“Long COVID-19” of Researchers: What to Do Next?
Переглядів 29Рік тому
“Long COVID-19” of Researchers: What to Do Next?

КОМЕНТАРІ

  • @marcosnevesi9
    @marcosnevesi9 9 місяців тому

    Sou do Brasil e tudo que eles dizem eu passei, tudo começou, com disfunção erétil, alguns episódios de embassamento nas vistas, formigamento nos pés, tornozelos inchados, e com o passar do tempo perda da força nas pernas, Comecei com o cardiologista pois pensei que poderia ser o coração, estava em ordem, pediu exames e viu que estava com vitamina B12 baixa e testosterona muito baixa, procurei um urologista e ele receitou injeções de testosterona e disse que em uma semana estaria bem não resolveu, procurei reumatologista e não tinha nenhuma doença, procurei neurologista e ele pediu exame de choque nas pernas e mão e deu polineuropatia desmielizante crônica, o neurologista pensou em ser esclerose múltipla fiz exame de líquido da medula e deu negativo, ele pediu ressonância magnética do abdômen e crânio e ele observou uma lesão óssea no quadril mas ele não disse nada, eu não satisfeito procurei um hematologista e ele disse provável que vc tenha guiliam barre, ia me tratar já aí disse a ele mas é a lesão óssea aí ele disse pera aí vamos fazer uma biopsia de medula provavelmente vc tem mieloma múltiplo, mas a biopsia deu negativo, eu não tinha anemia minha hemoglobina era alta tipo 19 e estava com o basso inchado. Aí o médico pediu uma biopsia na lesão com agulha dirigida e a amostra foi pra 3 laboratórios diferentes e disseram ser mieloma múltiplo, aí meu médico disse se queria tratar mais perto da minha casa deveria procurar um médico perto de casa pois com o diagnóstico seria tranquilo, procurei outro hematologista mas a consulta iria demorar 10dias eu estava ansioso pra começar a o tratamento pois já não conseguia andar mais direito não conseguia nem ficar em pé perdi completamente o equilíbrio procurei outro hematologista que iria me atender no dia seguinte e fui até ele e já me prescreveu o tratamento de mieloma daratumabe, dexametazona, e injeções na barriga, mas ele disse que achava ser outra doença por conta de não ter anemia pediu outra biopsia da medula e deu negativo, ele não conformado me disse pra fazer uma biopsia no centro cirúrgico pra colher material melhor e lá fui eu novamente pela 4vez, e passei depois com a 3 hematologista e ela disse não parecer ser mieloma achava ser outra doença. Mas a 4 biopsia disse ter plasmocitoma então era mieloma mesmo assim. Fiz 16 quimioterapia e 16 radioterapia e estava pra fazer entrevista com o médico tranplantador. Onde eu persebi que minha vista estava melhor pois nem óculos precisava usar mais aí pesquisei e achei uma matéria sobre poems e comecei a grifar meus sintomas e quase todos diziam ser poems aí liguei pro meu médico e disse que achava ser poems ele disse pra comentar com o médico tranplantador pois ele nunca tinha tratado de alguma pessoa com poems, quando relatei meus sintomas pro médico transplante ele disse vc tem um caso típico de poems e vc só vai melhora se fizer o transplante e assim eu fiz já faz 7 meses e estou melhorando mas o médico disse que tenho que tomar lenadomida pelo resto da vida. Mas hoje consegui caminhar 1km na esteira e estou muito feliz.

  • @Hear-WeGoGo
    @Hear-WeGoGo Рік тому

    Why aren't your video views increasing? And not reaching people? The reason is 1. Your video is not being SEO properly Your videos are great but your channel is not being optimized, if you want I can help you grow your channel